Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Duodenal ulcer - multicenter double-blind study with proglumide]

W Bergemann, K Consentius, H E Braun

    Medizinische Klinik
    |April 10, 1981
    PubMed
    Summary

    Proglumide significantly improved duodenal ulcer healing rates compared to antacids in a clinical trial. This effective drug demonstrated better outcomes for larger ulcers with no reported side effects.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    ECFS standards of care on CFTR-related disorders: Towards a comprehensive program for affected individuals.

    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2024
    Same author

    Letter to the editor: Risk of false newborn screening after intra-uterine exposure to ETI.

    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2023
    Same author

    Standards of care guidance for sweat testing; phase two of the ECFS quality improvement programme.

    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2022
    Same author

    Penetrance is a critical parameter for assessing the disease liability of CFTR variants.

    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2020
    Same author

    Newborn screening for CF in France: An exemplary national experience.

    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2020
    Same author

    Residues of Nine Insecticides and Two Fungicides in Raw and Processed Tomatoes.

    Journal of food protection·2019

    Area of Science:

    • Gastroenterology
    • Pharmacology

    Background:

    • Duodenal ulcers are a common gastrointestinal condition requiring effective treatment.
    • Current treatments include antacids, but novel therapeutic agents are continuously sought.

    Purpose of the Study:

    • To compare the efficacy of proglumide versus a standard antacid drug in healing chronic duodenal ulcers.
    • To evaluate healing rates, ulcer size reduction, and symptom changes in patients treated with proglumide or antacids.

    Main Methods:

    • A randomized, multicenter, double-blind study involving 70 patients with active duodenal ulcers.
    • Endoscopic and X-ray evaluations were performed before and after a four-week treatment period.
    • Healing rates were assessed in both inpatients and outpatients, with subgroup analysis for ulcer size.

    Related Experiment Videos

    Main Results:

    • Proglumide demonstrated a significantly higher healing rate (83%) compared to antacids (60%) overall (p < 0.05).
    • Inpatients treated with proglumide showed a significantly better healing rate (95%) than those on antacids (70%) (p < 0.05).
    • Larger duodenal ulcers (>120 mm2) exhibited significantly faster healing with proglumide.

    Conclusions:

    • Proglumide is an effective therapeutic option for healing chronic duodenal ulcers.
    • The drug was well-tolerated, with no observed side effects during the study.
    • Proglumide offers a promising alternative for managing duodenal ulcer disease, particularly for larger lesions.